ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in New Haven, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Pneumonia
Post-Acute COVID-19 Syndrome
Human Influenza
Respiratory Distress Syndrome

COVID-19 trials near New Haven, CT, USA:

Reparixin add-on Therapy to Std Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia

for infectious pneumonia acquired in the community (CAP), including COVID-19.Secondary objectives:- To determine the effect of repa...

Enrolling
Severe COVID-19
Infectious Pneumonia
Other: Placebo
Drug: Reparixin

Phase 3

Dompé
Dompé

Danbury, Connecticut, United States and 106 other locations

This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infe...

Active, not recruiting
COVID-19
Biological: Placebo
Biological: Remdesivir

Phase 3

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

West Haven, Connecticut, United States and 123 other locations

multi-center clinical trial (RCT) of SPI-1005 in adult subjects with positive PCR test for novel SARS-CoV-2 (nCoV2) and severe symptoms of COVID...

Invitation-only
Covid19
Corona Virus Infection
Drug: Ebselen
Drug: Placebo

Phase 2

Sound Pharmaceuticals

New Haven, Connecticut, United States and 6 other locations

multi-center clinical trial (RCT) of SPI-1005 in adult subjects with positive PCR test for novel SARS-CoV-2 (nCoV2) and moderate symptoms of COVID...

Invitation-only
Covid19
Corona Virus Infection
Drug: Ebselen
Drug: Placebo

Phase 2

Sound Pharmaceuticals

New Haven, Connecticut, United States and 6 other locations

The proposed trial will obtain preliminary data on the feasibility of studying RTB101 as compared to placebo for COVID-19 post-expo...

Active, not recruiting
Covid19
Drug: Placebo
Drug: RTB101

Phase 2

resTORbio

Farmington, Connecticut, United States and 1 other location

A randomized, double-blind, placebo-controlled Phase 2/3 Study of LAU-7b against confirmed COVID-19 Disease in hospitalized patient...

Active, not recruiting
COVID-19 Disease
Drug: Placebo oral capsule
Drug: LAU-7b

Phase 2, Phase 3

Laurent Pharmaceuticals

Danbury, Connecticut, United States and 28 other locations

The purpose of this clinical trial is to see if combining a licensed COVID-19 vaccine and a licensed influenza vaccine into a singl-...

Active, not recruiting
COVID-19
Influenza, Human
Other: Normal saline placebo
Biological: BNT162b2 (Omi XBB.1.5)

Phase 2

Pfizer
Pfizer

Milford, Connecticut, United States and 29 other locations

This is an exploratory Phase I, randomized, observer-blind, active-controlled, dose-escalation trial to evaluate four dose levels (DLs) of BNT162b4 g...

Active, not recruiting
COVID-19
SARS-CoV-2 Infection
Biological: BNT162b4 30 µg
Biological: BNT162b4 15 µg

Phase 1

BioNTech
BioNTech

Milford, Connecticut, United States and 16 other locations

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting
COVID-19, SARS-CoV-2
Biological: AZD3152 (Parent study Main Cohort)
Biological: AZD7442 (EVUSHELD™) (Sub-study) Immunocompromised participants offered AZD3152

Phase 2, Phase 3

AstraZeneca
AstraZeneca

New Haven, Connecticut, United States and 214 other locations

The study aims to evaluate MN-166 (ibudilast) in patients with COVID-19 who are at risk of developing acute respiratory distress sy...

Active, not recruiting
Pneumonia, Viral
Drug: Ibudilast
Drug: Placebo

Phase 2

MediciNova

New Haven, Connecticut, United States and 1 other location

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems